AzTrials
AzTrials

Cardiac ArrhythmiasE20PCNCT02326519

Electrical Signal Collection From a 20 Pole Catheter During Routine Cardiac Procedures

A study testing Intracardiac electrode catheter in people with Cardiac Arrhythmias, run by Medtronic Cardiac Rhythm and Heart Failure at 2 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Routine data collection will be conducted during normal sinus rhythm and AV synchronous pacing for approximately 20 minutes. The data collected will then be processed and the P, R and T wave amplitudes will be measured. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cardiac Arrhythmias
What is being tested?
Intracardiac electrode catheter
Could I receive a placebo?
No, everyone receives an active treatment
How many people
31 participants
Where
2 sitesin 2 countries
Study dates
1 Oct 2013to 13 Mar 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Subjects aged 18 or above, or of legal age to give consent specific to the national law of the countries in which the study is being conducted
  • Subjects who are undergoing a cardiac procedure where routine placement of cardiac catheter can be performed
  • Subjects are willing to provide Informed Consent

Who cannot join

  • • Subject has exclusion criteria per local law and regulations (e.g. age, breast feeding, etc)
  • Any condition which precludes the subject's ability to comply with the study requirements
  • Subject has physical conditions that contraindicate the use of the device per approved labeling, including but not limited to active sepsis, known sensitivity to heparin, cannot undergo standard anticoagulation protocol for cardiac procedure, blood clotting abnormalities or a recent coagulopathy or embolic event, venous filtering device (Greenfield Filter) and obstructed or damaged vessel

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

Austria1 site
  • Allgemeines Krankenhaus der Stadt Linz

    Linz

Other trials in Austria

France1 site
  • Hôpital Cardiologique du Haut-Lévêque

    Bordeaux

Other trials in France

About this study

Routine data collection will be conducted during normal sinus rhythm and AV synchronous pacing for approximately 20 minutes. The data collected will then be processed and the P, R and T wave amplitudes will be measured.

Read the detailed description

The purpose of this study is to collect atrio-ventricular electrograms using a sequence of tip-ring spacings in patients undergoing routine cardiac procedures (EP study, pacemaker/ICD/CRT implant). To collect these signals, a 20 pole catheter (Medtronic StableMapr intracardiac steerable electrode catheter) will be acutely placed in the RV apex during a routine cardiac procedure.

Routine data collection will be conducted during normal sinus rhythm and AV synchronous pacing for approximately 20 minutes. The data collected will then be processed and the P, R and T wave amplitudes will be measured.

Being tested
Intracardiac electrode catheter
Medical subject headings
Arrhythmias, Cardiac

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intracardiac electrode catheterOther

    All patient in the study will have the same data collected using the Steerable intracardiac electrode catheter

Study groups in NCT02326519
Study groupRoleWhat they receive
Intracardiac electrode catheterOtherAll patient in the study will have same data collected during the procedure using the Steerable intracardiac electrode catheter.
Receives: Other: Intracardiac electrode catheter

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The electrical signal mean amplitude (mv) during AV synchronous pacing.

    Measured: 2 minutes during the procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Dec 2014 (estimated)
  2. Study start1 Oct 2013
  3. Primary completion13 Jan 2015
  4. Study completion13 Mar 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
31 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02326519
Sponsor's protocol ID
E20PC study
Acronym
E20PC
Status last verified
Dec 2017
First submitted
10 Dec 2014
Last updated
20 Dec 2017
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Intracardiac electrode catheter in people with Cardiac Arrhythmias, run by Medtronic Cardiac Rhythm and Heart Failure at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Dec 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Austria, France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The electrical signal mean amplitude (mv) during AV synchronous pacing. (time frame: 2 minutes during the procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Dec 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in